UBE2D1 as a key biomarker in systemic juvenile idiopathic arthritis: a new perspective on diagnosis and disease activity assessment.

Arthritis Res Ther · 2025 · PMC12239252 · PMID 40635084

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Moreover, pseudotime analysis revealed a decreasing trend in the expression of UBE2D1 and associated NLRs pathway markers over time, while the expression of the IKB-α gradually increased.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.